Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
Small biotechnology company focused on discovering antibodies from natural sources for development into therapeutic products.
Carl Hansen, President
End date of the last completed financial year: 2019-12-31
|Government Institution||Funding Received in Last Financial Year||Funding Expected in Current Financial Year|
|Western Economic Diversification Canada (WD)||$289,116.00||Yes|
2215 Yukon Street
Vancouver, BC V5Y 0A1
AbCellera Biologics Inc. is not a subsidiary of any other parent companies.
AbCellera Biologics Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking